Business Context and Reporting Period
Company: Healthcare Acquisition Corp. (Note: Input metadata referenced "Altimmune, Inc.", but the filing text identifies the registrant as Healthcare Acquisition Corp., a Delaware corporation in the development stage).
Reporting Period: Quarterly period ended September 30, 2006.
Business Model: A "blank check" company formed to acquire an operating business in the healthcare industry. The company has no active operations other than searching for a target business. It must consummate a business combination by January 28, 2007 (or July 28, 2007 if extended), or it will liquidate.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2006 | Nine Months Ended Sep 30, 2006 |
|---|---|---|
| Total Revenues | $484,485 | $1,355,556 |
| Net Income | $301,141 | $789,485 |
| Basic EPS | $0.03 | $0.07 |
| Cash and Cash Equivalents | $763,931 | $763,931 |
| Cash Held in Trust | $70,283,506 | $70,283,506 |
| Total Current Liabilities | $697,905 | $697,905 |
| Stockholders' Equity | $56,886,893 | $56,886,893 |
Revenue Composition: Revenues consist entirely of interest income ($10,827 for the quarter) and interest/dividend income from the Trust Fund ($473,658 for the quarter).
Debt: The company has no long-term debt. Notes payable to stockholders were repaid in 2005.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased from $206,261 in the three months ended September 30, 2005, to $484,485 in the same period in 2006. This increase is primarily driven by higher interest income from the Trust Fund ($198,141 in 2005 vs. $473,658 in 2006).
- Expense Increase: Total expenses rose from $49,785 in Q3 2005 to $125,344 in Q3 2006. Notable increases include capital-based taxes ($22,693 vs. $0), management fees ($22,500 vs. $15,486), and travel expenses ($29,799 vs. $13,902).
- Net Income: Net income for the quarter more than doubled, rising from $146,476 in 2005 to $301,141 in 2006.
- Liquidity: Cash held in trust increased by approximately $1.65 million during the nine-month period due to accrued interest, while operating cash decreased slightly.
Outlook, Risks, and Management Commentary
- Liquidity and Runway: Management believes it has sufficient funds outside the trust to operate through August 2007, assuming no business combination is consummated. No additional fundraising is currently anticipated for operations.
- Liquidation Deadline: The company must complete a business combination by January 28, 2007, or July 28, 2007 (if extended). Failure to do so will result in mandatory liquidation and distribution of trust funds to public stockholders.
- Redemption Rights: Public stockholders may redeem their shares for a pro-rata share of the Trust Fund if they vote against a business combination. Approximately 19.99% of the trust proceeds are classified as "common stock subject to possible redemption."
- Risk Factors:
- Stockholder Liability: If the company liquidates without complying with specific Delaware General Corporation Law procedures (Section 280), stockholders could be held liable for third-party claims to the extent of distributions received.
- Trust Fund Claims: While the company seeks waivers from vendors, there is no guarantee that third parties will not make claims against the Trust Fund.
- Warrant Expiration: Warrants will expire worthless upon liquidation.
Investor Verification Checklist
- Company Identity: Verify that the filing is for "Healthcare Acquisition Corp." and not "Altimmune, Inc." as suggested in the metadata.
- Trust Fund Balance: Confirm the $70.28 million held in trust is invested in U.S. Treasury Bills or money market funds as disclosed.
- Redemption Liability: Review the $13.58 million classified as "common stock subject to possible redemption" to understand the potential cash outflow if a merger is rejected.
- Extension Criteria: Verify the specific criteria required to extend the liquidation deadline from January 2007 to July 2007.
- Related Party Transactions: Note the $7,500 monthly office services fee paid to an affiliate of an Initial Stockholder.